On September 9-10th, together with our distributor AspironiX, IntoCare made its first public appearance at Czech-Slovak congress of Petřivalský Rapant's Days in Olomouc, Czech Republic. The Congress fo···
On August 19th, Prof. Li Xinxiang's team from Fudan University Shanghai Cancer Center completed the first case of an enrolled patient in a multi-center clinical study of the app···
Since 1991, Minimal invasive surgery has entered in China for 30 years. Over the 30 years MIS wide-spread across China, taking over almost half of the national amount of surgery.
In 2015, Johnson & Johnson and Medtronic continued to dominate the powered stapler market. At that time, few Chinese companies kept up, but that’s when Eva Zhang, the CEO of IntoCare decided to take som···
A successful animal lab has just finished in Montreal Canada, performed by Dr. Ronald Denis. Dr. Denis is genuinely impressed by the stapling performance and advance concept of Into···
IntoCare Medical recently just finished the Series C Round Financing which is up to millions of RMB. Yuansheng Venture Capital led the investment, and former shareholder Qiming Venture Capital followed the i···
With a 3-month effort of all IntoCare members, IntoCare is very glad to share the good news with all friends and partners: Up till now all products in IntoCare™ Powered Stapling Platform are CE mar···
IntoCare Powered Stapling Platform with E-Stapling Technology, offers an ergonomic, intuitive and uniformed stapling system resulting in a reduced learning curve for surgeons and simplified ease of use, and boosts confidence in consistent anastomotic integrity for a safer surgery.